1.Clinical Characteristics of Cytomegalovirus Disease of the Upper Gastrointestinal Tract: A 10-Year Multicenter Retrospective Study
Ga-Ram YOU ; Seon-Young PARK ; Hye-Su YOU ; Seung-Young SEO ; Sung-Kyun YIM ; Byung-Chul JIN ; Jung-In LEE ; Young-Dae KIM ; Suck-Chei CHOI ; Chan-Guk PARK ; Wan-Sik LEE
The Korean Journal of Helicobacter and Upper Gastrointestinal Research 2023;23(4):294-301
Objectives:
Gastrointestinal cytomegalovirus (CMV) disease is a major contributor to mortality in immunocompromised patients. Few studies have discussed upper gastrointestinal CMV (UGICMV) disease in immunocompetent patients. We compared the clinical outcomes of UGI-CMV between immunocompromised and immunocompetent patients.
Methods:
This retrospective study included patients with UGI-CMV disease from five tertiary hospitals across Korea (2010– 2022). Patients’ clinical data and outcomes were recorded.
Results:
UGI-CMV was diagnosed in 54 patients; 27 (50.0%) had esophageal, 24 (44.4%) had gastric, and 3 patients (5.6%) had duodenal involvement. Patients’ median age was 64 years (interquartile range 53–75 years), and the most common comorbidities included hypertension (57.4%) and diabetes (38.9%). The predominant symptom was abdominal pain (46.3%), and the most common endoscopic finding was ulcers (70.4%). Antiviral treatment was administered to 31 patients, and 23 patients underwent observation without treatment. We investigated 32 immunocompromised (59.3%) and 22 immunocompetent (40.7%) patients and observed no intergroup differences in comorbidities and in laboratory and endoscopic findings. Immunocompromised patients had longer length of hospitalization (median 46.2 days vs. 20.0 days, p=0.001). However, treatment outcomes, including the need for intensive care unit admission and mortality did not significantly differ. The overall mortality rate was 13.0%; one patient from the immunocompromised group died of UGI-CMV disease. The treatment success rate was higher in immunocompromised patients who received antiviral therapy (p=0.011).
Conclusions
UGI-CMV disease is not uncommon in immunocompetent patients, although symptoms are milder than those in immunocompromised patients. Our findings emphasize the importance of clinical vigilance for accurate diagnosis of CMV infection, particularly in susceptible symptomatic patients and highlight the need for active antiviral treatment for management of immunocompromised patients.
2.Characteristics of Adult Severe Refractory Asthma in Korea Analyzed From the Severe Asthma Registry.
Min Hye KIM ; Sang Heon KIM ; So Young PARK ; Ga Young BAN ; Joo Hee KIM ; Jae Woo JUNG ; Ji Yong MOON ; Woo Jung SONG ; Hyouk Soo KWON ; Jae Woo KWON ; Jae Hyun LEE ; Hye Ryun KANG ; Jong Sook PARK ; Tae Bum KIM ; Heung Woo PARK ; Kwang Ha YOO ; Yeon Mok OH ; Young Il KOH ; An Soo JANG ; Byung Jae LEE ; Young Joo CHO ; Sang Heon CHO ; Hae Sim PARK ; Choon Sik PARK ; Ho Joo YOON ; You Sook CHO
Allergy, Asthma & Immunology Research 2019;11(1):43-54
PURPOSE: Although mild to moderate asthma is much more common, the morbidity and mortality of severe asthma are much higher. This study was performed to identify and analyze the clinical characteristics of severe asthma in Korea. METHODS: We registered patients with severe refractory asthma into the Severe Asthma Registry supported by the Severe Asthma Work Group of the Korean Academy of Asthma, Allergy and Clinical Immunology. Patients were enrolled since 2010 from the 15 university hospitals nationwide in Korea. Severe asthma was defined according to modified European Respiratory Society/American Thoracic Society criteria. Information on demographics, medical history, pulmonary function tests and skin prick tests was collected; the clinical characteristics of severe asthmatics were analyzed from the collected data. RESULTS: A total of 489 patients were enrolled with a mean age of 62.3; 45% are male. Sixty percent of patients received Global Initiative for Asthma step 4 treatment, and 30% received step 5 treatment. The most common comorbidities were allergic rhinitis (58.7%). Aspirin hypersensitivity was observed in 14.0%. Approximately half (53.9%) are non-smokers. Atopy was proven in 38.5% of the patients. Regarding asthma medications, inhaled corticosteroids and long-acting β-agonist combination inhalers were most commonly prescribed (96.5%), followed by leukotriene antagonists (71.0%). A recombinant anti-immunoglobulin E monoclonal antibody (omalizumab) has been used in 1.8% of the patients. The mean forced vital capacity (FVC), forced expiratory volume in 1 second (FEV1) and FEV1/FVC were 78.7%, 67.5% and 67.9% of predicted values, respectively. The mean Asthma Control Test and quality of life questionnaire scores were 16.5 out of 25 and 59.5 out of 85, respectively. CONCLUSIONS: The baseline characteristics of severe asthma patients in the Korea Severe Asthma Registry were analyzed and reported for the first time. With this cohort, further prospective studies should be performed to search for ways to improve management of severe refractory asthma.
Adrenal Cortex Hormones
;
Adult*
;
Allergy and Immunology
;
Aspirin
;
Asthma*
;
Cohort Studies
;
Comorbidity
;
Demography
;
Forced Expiratory Volume
;
Hospitals, University
;
Humans
;
Hypersensitivity
;
Korea*
;
Leukotriene Antagonists
;
Male
;
Mortality
;
Nebulizers and Vaporizers
;
Prospective Studies
;
Quality of Life
;
Respiratory Function Tests
;
Rhinitis, Allergic
;
Skin
;
Vital Capacity
3.Perceptions of Severe Asthma and Asthma-COPD Overlap Syndrome Among Specialists: A Questionnaire Survey.
Sang Heon KIM ; Ji Yong MOON ; Jae Hyun LEE ; Ga Young BAN ; Sujeong KIM ; Mi Ae KIM ; Joo Hee KIM ; Min Hye KIM ; Chan Sun PARK ; So Young PARK ; Hyouk Soo KWON ; Jae Woo KWON ; Jae Woo JUNG ; Hye Ryun KANG ; Jong Sook PARK ; Tae Bum KIM ; Heung Woo PARK ; You Sook CHO ; Kwang Ha YOO ; Yeon Mok OH ; Byung Jae LEE ; An Soo JANG ; Sang Heon CHO ; Hae Sim PARK ; Choon Sik PARK ; Ho Joo YOON
Allergy, Asthma & Immunology Research 2018;10(3):225-235
PURPOSE: Severe asthma and asthma-chronic obstructive pulmonary disease (COPD) overlap syndrome (ACOS) are difficult to control and are often associated with poor clinical outcomes. However, much is not understood regarding the diagnosis and treatment of severe asthma and ACOS. To evaluate the current perceptions of severe asthma and COPD among asthma and COPD specialists, we designed an e-mail and internet-based questionnaire survey. METHODS: Subjects were selected based on clinical specialty from among the members of the Korean Academy of Asthma, Allergy and Clinical Immunology and the Korean Academy of Tuberculosis and Respiratory Diseases. Of 432 subjects who received an e-mail invitation to the survey, 95 subjects, including 58 allergists and 37 pulmonologists, responded and submitted their answers online. RESULTS: The specialists estimated that the percentage of severe cases among total asthma patients in their practice was 13.9%±11.0%. Asthma aggravation by stepping down treatment was the most common subtype, followed by frequent exacerbation, uncontrolled asthma despite higher treatment steps, and serious exacerbation. ACOS was estimated to account for 20.7% of asthma, 38.0% of severe asthma, and 30.1% of COPD cases. A history of smoking, persistently low forced expiratory volume in 1 second (FEV1), and low FEV1 variation were most frequently classified as the major criteria for the diagnosis of ACOS among asthma patients. Among COPD patients, the highly selected major criteria for ACOS were high FEV1 variation, positive bronchodilator response, a personal history of allergies and positive airway hyperresponsiveness. Allergists and pulmonologists showed different assessments and opinions on asthma phenotyping, percentage, and diagnostic criteria for ACOS. CONCLUSIONS: Specialists had diverse perceptions and clinical practices regarding severe asthma and ACOS patients. This heterogeneity must be considered in future studies and strategy development for severe asthma and ACOS.
Allergy and Immunology
;
Asthma*
;
Diagnosis
;
Electronic Mail
;
Forced Expiratory Volume
;
Humans
;
Hypersensitivity
;
Lung Diseases, Obstructive
;
Population Characteristics
;
Pulmonary Disease, Chronic Obstructive
;
Smoke
;
Smoking
;
Specialization*
;
Tuberculosis
4.Sparganosis of the Unilateral Breast: A Case Report.
Hyung Suk KIM ; Man Sik SHIN ; Chang Jong KIM ; Sun Hyung YOU ; Yong Hwa EOM ; Tae Kyung YOO ; Ahwon LEE ; Byung Joo SONG ; Byung Joo CHAE
The Korean Journal of Parasitology 2017;55(4):421-424
Sparganosis is a parasitic infection caused by the sparganum, the plercercoid of the genus Spirometra. The preoperative diagnosis of breast sparganosis is difficult in most cases because it is a rare parasitic infection less than 2% of all cases. We report a 62-year-old woman case of breast sparganosis that were confirmed by surgical removal of worms from the right breast. The radiologic images of the patient also revealed characteristic features of breast sparganosis. The patient described the migrating palpable breast mass, which strongly suggested the possibility of breast sparganosis. The treatment of choice and confirmative diagnosis for sparganosis are complete surgical extraction of the sparganum irrespective of infected site. Inspection of the mass site with detailed medical history and radiological examinations are important for preoperative diagnosis of sparganosis patients.
Breast*
;
Diagnosis
;
Female
;
Humans
;
Mammography
;
Middle Aged
;
Sparganosis*
;
Sparganum
;
Spirometra
;
Ultrasonography
5.A Case of Chronic Myeloid Leukemia With Rare Variant ETV6/ABL1 Rearrangement.
Soo In CHOI ; Mi Ae JANG ; Woo Joon JEONG ; Byung Ryul JEON ; Yong Wha LEE ; Hee Bong SHIN ; Dae Sik HONG ; You Kyoung LEE
Annals of Laboratory Medicine 2017;37(1):77-80
No abstract available.
Bone Marrow/pathology
;
Chromosomes, Human, Pair 12
;
Chromosomes, Human, Pair 9
;
Core Binding Factor Alpha 2 Subunit/*genetics
;
DNA/metabolism
;
Gene Rearrangement
;
Humans
;
In Situ Hybridization, Fluorescence
;
Karyotyping
;
Leukemia, Myelogenous, Chronic, BCR-ABL Positive/diagnosis/*genetics
;
Male
;
Middle Aged
;
Oncogene Proteins, Fusion/*genetics
;
Reverse Transcriptase Polymerase Chain Reaction
;
Translocation, Genetic
6.Nipple-Areola Complex Necrosis after Nipple-Sparing Mastectomy with Immediate Autologous Breast Reconstruction.
Jin Woo CHO ; Eul Sik YOON ; Hi Jin YOU ; Hyon Surk KIM ; Byung Il LEE ; Seung Ha PARK
Archives of Plastic Surgery 2015;42(5):601-607
BACKGROUND: Autologous or implant-based breast reconstruction after nipple-sparing mastectomy is increasingly preferred worldwide as a breast cancer treatment option. However, postoperative nipple-areola complex (NAC) necrosis is the most significant complication of nipple-sparing mastectomy. The purpose of our study was to identify the risk factors for NAC necrosis, and to describe the use of our skin-banking technique as a solution. METHODS: We reviewed cases of immediate autologous breast reconstruction after nipple-sparing mastectomy at our institution between June 2005 and January 2014. The patients' data were reviewed and the risk of NAC necrosis was analyzed based on correlations between patient variables and NAC necrosis. Moreover, data pertaining to five high-risk patients who underwent the donor skin-banking procedure were included in the analysis. RESULTS: Eighty-five patients underwent immediate autologous breast reconstruction after nipple-sparing mastectomy during the study period. Partial or total NAC necrosis occurred in 36 patients (43.4%). Univariate analysis and binary regression modeling found that body mass index, smoking history, radiation therapy, and mastectomy volume were significantly associated with NAC necrosis. Of the 36 cases of NAC necrosis, 31 were resolved with dressing changes, debridement, or skin grafting. The other five high-risk patients underwent our prophylactic skin-banking technique during breast reconstruction surgery. CONCLUSIONS: NAC necrosis is common in patients with multiple risk factors. The use of the skin-banking technique in immediate autologous breast reconstruction is an attractive option for high-risk patients. Banked skin can be used in such cases without requiring additional donor tissue, with good results in terms of aesthetic and reconstructive outcomes.
Bandages
;
Body Mass Index
;
Breast Neoplasms
;
Breast*
;
Debridement
;
Female
;
Humans
;
Mammaplasty*
;
Mastectomy*
;
Necrosis*
;
Nipples
;
Risk Factors
;
Skin
;
Skin Transplantation
;
Smoke
;
Smoking
;
Surgical Flaps
;
Tissue Donors
7.Reversal of Hypoglycemia Unawareness with a Single-donor, Marginal Dose Allogeneic Islet Transplantation in Korea: A Case Report.
Hae Kyung YANG ; Dong Sik HAM ; Heon Seok PARK ; Marie RHEE ; Young Hye YOU ; Min Jung KIM ; Ji Won KIM ; Seung Hwan LEE ; Tae Ho HONG ; Byung Gil CHOI ; Jae Hyoung CHO ; Kun Ho YOON
Journal of Korean Medical Science 2015;30(7):991-994
Pancreatic islet transplantation is a physiologically advantageous and minimally invasive procedure for the treatment of type 1 diabetes mellitus. Here, we describe the first reported case of successful allogeneic islet transplantation alone, using single-donor, marginal-dose islets in a Korean patient. A 59-yr-old patient with type 1 diabetes mellitus, who suffered from recurrent severe hypoglycemia, received 4,163 islet equivalents/kg from a single brain-death donor. Isolated islets were infused intraportally without any complications. The immunosuppressive regimen was based on the Edmonton protocol, but the maintenance dosage was reduced because of mucositis and leukopenia. Although insulin independence was not achieved, the patient showed stabilized blood glucose concentration, reduced insulin dosage and reversal of hypoglycemic unawareness, even with marginal dose of islets and reduced immunosuppressant. Islet transplantation may successfully improve endogenous insulin production and glycemic stability in subjects with type 1 diabetes mellitus.
Blood Glucose/analysis
;
Diabetes Mellitus, Type 1/*surgery
;
Female
;
Humans
;
Hypoglycemia/*surgery
;
Immunosuppression/methods
;
Immunosuppressive Agents/therapeutic use
;
Islets of Langerhans/physiology/*surgery
;
Islets of Langerhans Transplantation/*methods
;
Middle Aged
;
Republic of Korea
;
Tissue Donors
8.Stabilizing Morbidity and Predicting the Aesthetic Results of Radial Forearm Free Flap Donor Sites.
Tae Kyoung YUN ; Eul Sik YOON ; Duck Sun AHN ; Seung Ha PARK ; Byung Il LEE ; Hyon Surk KIM ; Hi Jin YOU
Archives of Plastic Surgery 2015;42(6):769-775
BACKGROUND: The radial forearm flap is a versatile, widely used flap. However, the possibility of donor site complications has led to concern over its use. Some surgeons prefer using other flaps whose donor sites can be closed primarily with less morbidity, including avoiding unpleasant scarring. However, in our experience, donor site stability of the radial forearm flap can be reliably achieved by using well-implemented specific procedures. Here, we present a collection of donor site cases of the radial forearm flap and investigate factors that affect the aesthetic results as the basis for a reference for selecting a radial forearm flap. METHODS: In this retrospective study, we reviewed 171 cases in which a radial forearm flap was used for free tissue transfer after resecting head and neck cancer. We focused on donor site morbidity rates. Each operation involved a detailed procedure designed to minimize donor site morbidity. Moreover, statistical investigations were conducted for 22 cases to determine factors affecting the scar appearance. RESULTS: Only one case developed total skin graft necrosis as a major complication. Scar-related aesthetic results were acceptable, and the body-mass index, body weight, diabetes, and cardiac problems were significant factors related to the appearance of scars. CONCLUSIONS: Performing the radial forearm flap using a well-implemented detailed technique helps achieve acceptable donor site morbidity results. The aesthetic results were more promising for patients without excess body weight, diabetes, or cardiac problems. Therefore, anxiety about donor site morbidity should not be a reason to avoid selecting the radial forearm flap in suitable patients.
Anxiety
;
Body Weight
;
Cicatrix
;
Esthetics
;
Forearm*
;
Free Tissue Flaps*
;
Head and Neck Neoplasms
;
Humans
;
Necrosis
;
Retrospective Studies
;
Skin
;
Skin Transplantation
;
Tissue Donors*
;
Transplants
9.Inadvertent Transmission of a Donor's Constitutional Chromosome Abnormality after Hematopoietic Stem Cell Transplantation.
Jina YUN ; Hyun Ho JO ; Byung Ryul JEON ; You Kyoung LEE ; Chan Kyu KIM ; Seong Kyu PARK ; Dae Sik HONG
Soonchunhyang Medical Science 2015;21(2):137-141
A pre-transplant screening work-up of donors for allogeneic hematopoietic stem cell transplantation (HSCT) is essential. Inadvertent transmission of malignancy from donors with subclinical diseases to recipients has been reported recently in several cases. A 49-year-old male was diagnosed with acute myeloid leukemia. He underwent a course of induction chemotherapy and achieved cytogenetic complete remission (CR). He was treated with an additional cycle of consolidation chemotherapy followed by full matched sibling allogeneic HSCT due to an additional deletion in 9q known as an adverse prognostic factor. Post transplantation bone marrow biopsy revealed molecular CR, but conventional cytogenetics identified the presence of 46,XY,t(1:2)(p32:q35). A cytogenetic analysis of the donor graft specimen revealed t(1:2). We confirmed the donor origin of t(1:2). We report the first case of a person with constitutional t(1;2) serving as a stem cell donor.
Biopsy
;
Bone Marrow
;
Chromosome Aberrations*
;
Consolidation Chemotherapy
;
Cytogenetic Analysis
;
Cytogenetics
;
Hematopoietic Stem Cell Transplantation*
;
Hematopoietic Stem Cells*
;
Humans
;
Induction Chemotherapy
;
Leukemia
;
Leukemia, Myeloid, Acute
;
Male
;
Mass Screening
;
Middle Aged
;
Siblings
;
Stem Cells
;
Tissue Donors
;
Transplants
10.Comparison of the Complications in Vertical Rectus Abdominis Musculocutaneous Flap with Non-Reconstructed Cases after Pelvic Exenteration.
Heechang JEON ; Eul Sik YOON ; Hi Jin YOU ; Hyon Surk KIM ; Byung Il LEE ; Seung Ha PARK
Archives of Plastic Surgery 2014;41(6):722-727
BACKGROUND: Perineal reconstruction following pelvic exenteration is a challenging area in plastic surgery. Its advantages include preventing complications by obliterating the pelvic dead space and minimizing the scar by using the previous abdominal incision and a vertical rectus abdominis musculocutaneous (VRAM) flap. However, only a few studies have compared the complications and the outcomes following pelvic exenteration between cases with and without a VRAM flap. In this study, we aimed to compare the complications and the outcomes following pelvic exenteration with or without VRAM flap coverage. METHODS: We retrospectively reviewed the cases of nine patients for whom transpelvic VRAM flaps were created following pelvic exenteration due to pelvic malignancy. The complications and outcomes in these patients were compared with those of another nine patients who did not undergo such reconstruction. RESULTS: Flap reconstruction was successful in eight cases, with minor complications such as wound infection and dehiscence. In all cases in the reconstructed group (n=9), structural integrity was maintained and major complications including bowel obstruction and infection were prevented by obliterating the pelvic dead space. In contrast, in the control group (n=9), peritonitis and bowel obstruction occurred in 1 case (11%). CONCLUSIONS: Despite the possibility of flap failure and minor complications, a VRAM flap can result in adequate perineal reconstruction to prevent major complications of pelvic exenteration.
Cicatrix
;
Humans
;
Myocutaneous Flap*
;
Pelvic Exenteration*
;
Peritonitis
;
Rectus Abdominis*
;
Retrospective Studies
;
Surgery, Plastic
;
Wound Infection

Result Analysis
Print
Save
E-mail